• $5.02 million in customer receipts for Q1 2025
• $2.62 million in net cash used in operating activities, including $1.3 million in non-recurring costs
• $2.08 million in available funding at quarter-end

Althea Group Holdings Ltd (ASX:AGH) reported its quarterly activities report for the period ending 31 March 2025. The company recorded $5.02 million in customer receipts for the quarter, with its Canada-based wholly owned subsidiary Peak Canada achieving $4.2 million in customer receipts. However, the company's pharmaceutical cannabis division Althea saw an 81% decline in cash receipts compared to the prior corresponding period, despite $3.9 million in annualized cost savings. The company is undertaking a strategic review of the Althea division to explore options to restore sustainable profitability or maximize shareholder value. Peak USA, the company's U.S.-based wholly owned subsidiary, successfully commenced commercial manufacturing operations during the quarter, with over 550,000 units produced or shipped within weeks of launch. The company also completed capital raising initiatives that delivered $4 million in funding during the quarter.

The company did not provide any high-importance, price-sensitive forward-looking financial metrics.

The company stated that its Peak Canada and Peak USA businesses are well-positioned to drive significant revenue and profitability growth into FY26 and beyond, with the strategic review of the Althea division ongoing.